254
Participants
Start Date
July 31, 2015
Primary Completion Date
December 6, 2019
Study Completion Date
January 17, 2020
NGM282
Placebo
NGM Clinical Study Site 703, Sydney
NGM Clinical Study Site 701, Melbourne
NGM Clinical Study Site 705, Melbourne
NGM Clinical Study Site 704, Adelaide
NGM Clinical Study Site 904, Charlottesville
NGM Clinical Study Site 911, Richmond
NGM Clinical Study Site 903, Durham
NGM Clinical Study Site 917, Lakewood Rch
NGM Clinical Study Site 921, Germantown
NGM Clinical Study Site 906, Chicago
NGM Clinical Study Site 918, Kansas City
NGM Clinical Study Site 910, Dallas
NGM Clinical Study Site 909, San Antonio
NGM Clinical Study Site 905, San Antonio
NGM Clinical Study Site 920, Rollingwood
NGM Clinical Study Site 922, Chandler
NGM Clinical Study Site 923, Tucson
NGM Clinical Study Site 924, Los Angeles
NGM Clinical Study Site 901, San Diego
NGM Clinical Study Site 908, Seattle
NGM Clinical Study Site 902, Denver
NGM Clinical Study Site 916, San Juan
Lead Sponsor
Collaborators (1)
NGM Biopharmaceuticals Australia Pty Ltd
INDUSTRY
NGM Biopharmaceuticals, Inc
INDUSTRY